Please login to the form below

Not currently logged in
Email:
Password:

insomnia

This page shows the latest insomnia news and features for those working in and with pharma, biotech and healthcare.

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals

The first of the new products is RAD Neurim Pharma’s Slenyto, a small-tablet formulation of the hormone melatonin for the treatment of insomnia in children and adolescents with autism ... There are currently no approved medicines to treat insomnia in

Latest news

More from news
Approximately 5 fully matching, plus 85 partially matching documents found.

Latest Intelligence

  • Pharma deals in September 2015 Pharma deals in September 2015

    Let's deal with the pain first …. After last month's deal with Eisai for lemborexant, a phase III insomnia treatment, Purdue Pharma is refocusing on its pain portfolio by

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics